Literature DB >> 15993473

Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties.

Bjarne Madsen Härdig1, Hans W Persson, S Bertil Olsson.   

Abstract

INTRODUCTION: This study explores the mechanisms of ultrasound-enhanced fibrinolysis by investigating the effects of pre-exposure to pulsed high-frequency, low-energy ultrasound on the fibrinolytic properties of streptokinase.
MATERIALS AND METHODS: Fibrinolytic activity was measured as haemoglobin release from blood clots. The fibrinolytic effects of streptokinase and ultrasound separately and in combination were studied by evaluating cumulative percentages of haemoglobin release following 1 h of exposure using two clots, one for intervention and the other concomitantly as control. In particular, the effects of exposure to ultrasound on clot-free streptokinase solution were compared to those of concomitant exposures of streptokinase solution with clot. The exposures were made at a frequency of 1 MHz (10% duty cycle) and at three intensity levels (0.5, 1.0 and 4.0 W/cm2 intensity I(SATA)).
RESULTS: Increased fibrinolysis (31.2%, P=0.028) was observed after concomitant ultrasound exposure of clot and streptokinase solution at 0.5 W/cm2 intensity. Compared to unexposed streptokinase solution, the lytic effect following exposure of streptokinase solution to ultrasound was significantly increased (32.7%, P=0.002). This enhancement effect disappeared at intensity 1 W/cm2, whilst further increase to 4.0 W/cm2 inhibited the lytic effect of streptokinase, both during concomitant exposure (-25.2%, P=0.028) and after pre-exposure of streptokinase solution to ultrasound (-25.4%, P=0.002).
CONCLUSION: The fibrinolytic property of streptokinase is modulated by exposure to pulsed ultrasound of frequency 1 MHz, being enhanced at low intensity and inhibited at high intensity.

Mesh:

Substances:

Year:  2005        PMID: 15993473     DOI: 10.1016/j.thromres.2005.05.027

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model.

Authors:  Christy K Holland; Sampada S Vaidya; Saurabh Datta; Constantin-C Coussios; George J Shaw
Journal:  Thromb Res       Date:  2007-09-14       Impact factor: 3.944

Review 2.  Advanced drug delivery systems for antithrombotic agents.

Authors:  Colin F Greineder; Melissa D Howard; Ronald Carnemolla; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

3.  Ultrasound-assisted thrombolysis with streptokinase improves thrombus resolution with minimal distal embolisation.

Authors:  Igor Adzerikho; Eduard Shantsila; Vladimir Minchenya; Anatoly Kulak
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

4.  Dutch randomized trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thromboembolic infrainguinal disease (DUET): design and rationale.

Authors:  A Marjolein Schrijver; Michel M P J Reijnen; Jacques A van Oostayen; Rudolf P J Tutein Nolthenius; Pieter H M van der Valk; Arjan W J Hoksbergen; Rutger J Lely; Bram Fioole; Dammis Vroegindeweij; Marc van Leersum; Jean-Paul P M de Vries
Journal:  Trials       Date:  2011-01-23       Impact factor: 2.279

5.  Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone.

Authors:  Bjarne Madsen Härdig; Jonas Carlson; Anders Roijer
Journal:  BMC Cardiovasc Disord       Date:  2008-08-26       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.